Investing Profile

Bruno Montanari

VCInvestor
Partner at Seroba.
Photo of Bruno Montanari, Partner at Seroba Life Sciences

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Deutsche Bank Network
249 CONNECTIONS
Merrill Lynch Network
248 CONNECTIONS
HEC Paris Network
127 CONNECTIONS
Mount Auburn Hospital Network
102 CONNECTIONS
Atlas Venture Network
31 CONNECTIONS
cb
$100K - $5.0M
$1.5M
6
CompanyStageDateRound SizeTotal Raised
Sibylla Biotech
Series AOct 2022$23M
$23M
Co-investors: Ciro Spedaliere (Claris Ventures), Marianne Bjørdal (Helsinn Group)
Storm Therapeutics
Series AMay 2019$18M
$130M
Co-investors: Hakan Goker (MDC Ventures (formerly KBS Ventures)), Sakae Asanuma (Hotmail), Robert Tansley (Cambridge Innovation Capital)
TISSIUM
Series AMar 2016$25M
Series ADec 2013$11M
$150M
Co-investors: Catherine Boule (Karista), Antoine Papiernik Papiernik (Sofinnova Partners)
Opsona
Series COct 2013$4M
$75M
Co-investors: Florent Gros (Earlybird Venture Capital), Martin Münchbach (Pureos Bioventures)
Novate Medical
Series BMay 2011$12M
$12M
Co-investors: Daniel O'Mahony (Seroba Life Sciences)
Analyst (HC Group) Deutsche BankPresent
Analyst (HC Group + Private Placement) Merrill LynchPresent
Investment Manager (Biotech) Le Centre CDP CapitalPresent
Principal Atlas VenturePresent
Independent advisor (life sciences) Mount Auburn HospitalPresent
Partner (venture capital) OmnesPresent
Partner Seroba.Present
Université Paris Descartes PharmD Pharmacy - Industry/biotech
INSEP PharmD Pharmacy - Industry/biotech
Université Paris Cité PharmD Pharmacy - Industry/biotech
HEC Paris Master Strategy
Sign in with Google →
Sign in with Google →